Comprehensive consulting services to a range of clinical, disease management, in vitro diagnostics and clinical laboratory programs nationwide. Representative engagements include:National Roll Out. Designed and implemented a national program of in house laboratory testing to manage risk and improve outcomes for a publicly traded venous access and dialysis company.Product Launch and Competitive Marketing. Conducted the technology assessment, competitive marketing analysis/pricing and served as subject matter expert for the sales force of a publically traded in vitro diagnostics company introducing an infertility screening instrument.Feasibility Analysis. Developed business plans to analyze the feasibility of taking clinical programs private to increase profitability and enhance patient satisfaction for several large medical school based specialty programs.Mergers and Acquisitions Assessment: Evaluated the operational, strategic marketing and development pipeline synergies of acquisition targets for a publically traded in vitro diagnostics company in the infectious disease space.Strategic Alliances and Product Development. Built strategic alliances to commercialize a new diagnostic/ therapeutic product positioned to expand the oncofertility market by 30% internationally.Managed the intellectual property portfolio and developed a regulatory compliance strategy.Network and Business Development. Spearheaded, as member of a three person team, the roll out of specialty women’s healthcare services to a network of 300 practices throughout New England.

Extensive hands-on laboratory and management experience in high complexity and moderate complexity diagnostictesting including Embryology, Clinical In Vitro Fertilization, Endocrinology, Andrology, Tissue Banking, Cryobiology, Transplant and Hematology. Expertise in build-out, staffing, training, policy/ procedure development and regulatory aspects of specialty and reference laboratory operations, clinical referral network expansion and national roll out. Responsible for world’s first test tube triplets.Board Certification and Licensure: High Complexity Clinical Laboratory Director, HCLD (ABB); Clinical Consultant, CC (ABB); Embryology Laboratory Director, ELD. Licensed to direct and perform high complexity clinical laboratory testing in New York State, Nevada and North Dakota.

Nationwide network of physicians, specialists and laboratories providing clinical services that increase the quality of life of young cancer survivors.Network Development. Established a national, interdisciplinary network of 60 provider centers to deliver specialized clinical services to pediatric/young adult cancer survivors. This national rollout occurred in just 3 years and exceeded the original goal of 15 centers over 5 years.Market Expansion and Best Practices Implementation. Leveraged existing unused clinical capacity to accelerate care delivery to new patient populations (oncology, rheumatology, neurology) that increased volume by 15%. Evaluated and implemented best practices, revenue cycle planning, on line tools and new technologies to improve access to care and patient and provider satisfaction while containing startup costs.Nationwide Referral and Growth Strategy. Built a nationwide referral hotline with complementary websites to promote national awareness, patient/provider access to services and educational resources. Increased referrals and follow up procedures by threefold.Relationship Building/Strategic Alliances. Shortened the cycle of clinical innovation and basic research by identifying areas of collaboration and subcontracting with biotech/in vitro diagnostics companies to improve reproducibility of results, reduce costs and improve access to care nationally.Third Party Payor Reimbursement/Managed Care Contracting. Built the business case to convince CMO level insurance plan leaders to change reimbursement policies for special groups of oncology patients. Served as in house expert on billing, collection and appeals for specialty services.Compliance Strategy. Implemented an integrated framework for regulatory compliance and risk management that improved patient outcomes and operational excellence throughout the network . This included inspection, accreditation and audit (FDA, JCAHO, CAP, Biospecimen Repositories, etc.).

National physician practice management company which used a disease management model and strategic managed care contracting to provide cost effective specialty care in both private and academic women’s health services including high risk obstetrics, infertility, endocrinology and genetics. Network Development. Led the team that grew a national physician practice management company's revenue by 50% and network from 7 sites locally to 25 sites nationally in less than two years.Acquisition Analysis. Evaluated acquisition targets, performed due diligence and developed logistical plans for merging practices, which decreased the time lines for operational integration and revenue realization.National Roll Out. Developed successful model for complete turn-key operations of specialty healthcare operations which was implemented nationwide.